En News 2018 ZonMw Top Grant for Martijn Huijnen and Ulrich Brandt

1 February 2018

Martijn Huijnen and Ulrich Brandt, theme Mitochondrial diseases received a ZonMw Top grant of € 675,000 for a project entitled: Complexome remodelling in mitochondrial disease.

Martijn Huijnen

Cells need to respond continuously to challenges imposed by variations in nutrient supply, hormonal signals and pathogenic factors, like genetic deficiencies or insults. At the molecular level, this is achieved by a complex network of adaptive and compensatory mechanisms. The advent of such integrated understanding of cellular function has led to a fundamental paradigm change in biomedical sciences from a purely monocausal to a comprehensive systems approach in which “omics” technologies have become increasingly important to assess of the molecular inventory of cells and its dynamics. We here propose to expand and complement already available resources by comprehensive complexome analyses to assess the state and dynamics of multiprotein complexes in health and disease, providing a level of information of the state of the cell that is closest to the functioning of its proteins. For this, we will apply our newly developed complexome profiling approach as a powerful proteomics based tool to directly obtain and study the full inventory, size and composition of multiprotein assemblies with high-resolution, high specificity and sensitivity.

Within this project, we will focus on mitochondria, since their function is central to cellular function and survival. They are involved in a broad range of diseases from inherited disorders to neuro-de¬gene¬ration and cancer and are considered to play a critical role in biological ageing. The overarching goal is to decipher mechanisms for maintaining mitochondrial homeostasis at the level of multiprotein complexes and to reveal their role in pathogenic mechanisms leading to mitochondrial disease and mitochondria-linked degenerative disorders. We will first define the complexome of normal cells and its functional remodelling induced by genetic or external challenges. We will then study the role of these mechanisms in selected models of mitochondrial disease and build a functional complexome database accessible to the scientific community for comparative analyses. The complexome data will comprise the inventory of proteins and their presence and relative abundance in multiprotein assemblies including the information on the apparent molecular mass ranging from 10 kDa to ~4 MDa and therewith the multimeric state of the complexes. The dataset will be complemented by a set of parameters diagnostic for mitochondrial function that will be measured following established standardized protocols.

We will obtain valuable insights into the functional complexome remodelling network that can be expected to be highly relevant for the understanding of many pathological conditions involving mitochondria, like Parkinson’s and Alzheimer’s disease, diabetes, cancer and ageing. This will guide the development of relevant biomarkers, as well as preventive and therapeutic approaches. Since complexomics are applicable and relevant for essentially all aspects of cellular function, our approach bears the potential to have broad impact on biomedical science as a whole.

Ulrich Brandt

 

Related news items


Cognitive behavioral therapy effective in MD1 New treatment option for complex disease

21 September 2018

Treatment with cognitive behavioral therapy helps patients with myotonic dystrophy type 1 in improving their physical abilities and social participation. This is the result of a survey of more than 250 patients in four European countries.

read more

Rebecca Halbach receives poster prize at EMBO conference

20 September 2018

Rebecca Halbach, theme Infectious diseases and global health, has received a poster prize at the EMBO Workshop ‘piRNAs and PIWI proteins’, held in Montpellier, France.

read more

Netherlands X-omics Initiative: Consortium kick off meeting

20 September 2018

The Netherlands X-omics Initiative had their consortium kick-off meeting. Consortium members from the Dutch partners involved gathered to get to know each other and to determine the next steps to start up the project.

read more

Last chance to register for ENABLE 2018

20 September 2018

The 2nd ENABLE symposium entitled “The promise of future medicine: from research to therapy” will be hosted in Copenhagen, from 7 - 9 November. Don’t miss out, registration closes 30 September.

read more

A personal touch of Carine van der Vleuten

20 September 2018

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Carine van der Vleuten.

read more

Successful teamwork between Neurology and Human Genetics leads to identification of two new ataxia genes

19 September 2018

Thanks to close cooperation between Bart van de Warrenburg (Neurology) and Erik-Jan Kamsteeg (Humans Genetics) two new genes involved in movement disorders were identified. The genes are relevant for autosomal recessive cerebellar ataxia.

read more
  • Go to